Commercial CBD Products Caused Neurotoxicity Linked to Heavy Metal Contamination | Research

The takeaway

Two commercial CBD powder products containing lead, chromium, and other heavy metals caused oxidative stress, mitochondrial damage, and reduced viability in human neuronal cells.

CBD consumers, regulators, toxicologists, and anyone concerned about product safety in the cannabinoid market.

What the researchers found

Treatment with commercial CBD samples at 50 micrograms/mL significantly increased reactive oxygen species, reduced the GSH/GSSG ratio (indicating oxidative stress), elevated lipid peroxidation, inhibited key antioxidant enzymes (CAT, SOD, GPx, GR), and decreased mitochondrial content in neuroblastoma cells.

Why it matters

The CBD market has grown faster than regulation can keep pace. This study provides concrete laboratory evidence that contaminated products can damage neurons, underscoring calls for mandatory testing and quality standards.

The numbers in context

Both samples contained ~51% CBD. White sample contaminated with boron, lead, silicon, zinc. Pink sample contaminated with boron, iron, silicon, chromium. At 10 and 50 micrograms/mL, both samples reduced cell viability in a concentration-dependent manner. All four major antioxidant enzymes were significantly inhibited at 50 micrograms/mL.

How the study worked

Two commercially available CBD powder samples were analyzed for cannabinoid content and elemental contamination, then applied to SH-SY5Y neuroblastoma cells at various concentrations for 48 hours. Oxidative stress markers, antioxidant enzyme activity, and mitochondrial function were assessed.

What this study cannot tell us

Only two commercial products tested. Cell culture conditions do not replicate human exposure. Cannot separate CBD effects from heavy metal effects. Neuroblastoma cells may respond differently than normal neurons. Concentrations used may not reflect realistic brain tissue levels.

How to read the evidence

Laboratory study with appropriate controls and multiple outcome measures, but only two products tested and cell culture results have limited human applicability.

When this study was published

Published 2025.

The bigger picture

Previous studies have documented widespread mislabeling and contamination in CBD products, but few have directly measured the biological consequences. This study bridges that gap by showing that real commercial products can cause measurable cellular damage, adding urgency to regulatory discussions.

Questions still open

How much of the neurotoxicity was from CBD itself versus the heavy metal contamination
What percentage of commercial CBD products would produce similar results

Common questions

Should I be worried about the CBD products I use?

This study tested only two products and found contamination in both. Third-party tested products with certificates of analysis (COAs) from reputable labs are less likely to have these issues, but the study highlights why independent testing matters.

Was the damage from CBD or from the contaminants?

The study could not fully separate the two. Both products contained similar CBD levels but different metal contaminants and produced similar neurotoxic effects, suggesting that contamination contributed significantly.

Read the original research

Oxidative stress and mitochondrial dysfunction in neuronal cells induced by commercial CBD products.

Chemico-biological interactions, 421, 111785

View on PubMed ↗Publisher’s paper ↗

Citation

Sanz-Pérez, A; Anaya, B J; Fraguas-Sánchez, A I; Serrano, D R; Pérez, T; Spineli, M; Basilicata, P; Pieri, M; González-Burgos, E. (2025). Oxidative stress and mitochondrial dysfunction in neuronal cells induced by commercial CBD products.. Chemico-biological interactions, 421, 111785. https://doi.org/10.1016/j.cbi.2025.111785